Acetazolamide
- Generic Name
- Acetazolamide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C4H6N4O3S2
- CAS Number
- 59-66-5
- Unique Ingredient Identifier
- O3FX965V0I
- Background
One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of...
- Indication
For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma
- Associated Conditions
- Acute angle-closure glaucoma, Edema, Familial periodic paralysis, Generalized Tonic-Clonic Seizures, Metabolic Alkalosis, Open Angle Glaucoma (OAG), Other and unspecified effects of high altitude, Cystine renal calculi, Drug-induced edema, Nonuveitic secondary glaucoma, Salicylate intoxication
- Associated Therapies
- Urine alkalinization therapy
Effects of Potassium Citrate in Urine of Children With Elevated Calcium in Urine and Kidney Stones
Not Applicable
Withdrawn
- Conditions
- First Posted Date
- 2005-07-19
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Children's Mercy Hospital Kansas City
- Registration Number
- NCT00120731
- Locations
- 🇺🇸
The Children's Mercy Hospital, Kansas City, Missouri, United States
Sleep Apnea: Mechanism and Cerebrovascular Consequences
- First Posted Date
- 2005-04-18
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- US Department of Veterans Affairs
- Registration Number
- NCT00108602
Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
Phase 2
Completed
- Conditions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000115
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath